Formulation, Characterization and In vitro Drug Delivery of Vitexin Loaded Liposomes

DOI:

https://doi.org/10.37285/ijpsn.2021.14.2.2

Authors

  • Dr.S.Bhagavathy Sivathanu Mohamed Sathak College of Arts and Science
  • Shivapriya G
  • Shivapriya G

Abstract

Liposome is a spherical vesicle which contains atleast one lipid bilayer. Liposomes are used as a novel drug carriers because of its hydrophobic and hydrophilic nature, it has many advantages in the field of medical sciences. There are some other drug carriers like dendrimers, micelles, niosomes. Out of all, liposomes are considered to be the most promising agent for drug delivery. The uniqueness of liposome is when it is used as a pharmaceutical drug, it acts as a natural receptor. Thus it acts as an antigen and binds with the antibody (cancer cell) without causing any damage to the adjacent cells. For the synthesis of liposomes, a phospholipid is required. The liposomes can be synthesized using egg yolk and chloroform. So the basic phospholipid is obtained from egg yolk. For more stability, the liposomes are prepared using popc. The present work  discuss about the effective preparation of drug loaded liposomes using popc (1- palmitoyl-2-oleoyl-sn-glycero-3- phosphocholine). POPC is an important phospholipid for biophysical experiments. Additionally chloroform is used as the solvent for the liposome preparation. The drug chosen for liposome loading is vitexin (vxn), which is an effective therapeutic agent against inflammation and cancer. The vesicular size, shape, drug entrapment efficacy, stability, electrochemical property and drug releasing property of the formulated liposomes were characterized. The results showed that the formulated liposomes are considered as the better drug carrier system and good choice for biotransformation within the cell to reach the target site such as cancer cells. Even though available treatments like chemotherapy and radiation therapy, causes damage to the surrounding cells, the alternative drug transferring system such as liposomal mediated drug transfer within the cell is considered as good choice of treatment to avoid such complications. The aim of liposome mediated  drug carrier system is to develop a method to reach the drug to the target site. After drug delivery at the target site, the liposomes are fused within the surface of the body. This is because of the pH of liposomes, which is at 7.4 and temperature is maintained at 37 oC. So, the vxn loaded liposomes are considered as the novel drug carriers for the successful targetted drug delivery.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Liposomes, Drug carrier, Cancer, Chloroform, Drug delivery, Vitexin

Downloads

Published

2021-04-30

How to Cite

1.
Sivathanu D, G S, G S. Formulation, Characterization and In vitro Drug Delivery of Vitexin Loaded Liposomes. Scopus Indexed [Internet]. 2021 Apr. 30 [cited 2024 Nov. 19];14(2):5364-71. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/1885

Issue

Section

Research Articles

References

Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al., (2013). Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8: 1.

Akbarzadeh A, Samiei M and Davaran S (2012a). Magnetic nano- particles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7: 1.

Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrab adi HT, et al., (2012b). Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol. 10:1.

Amelia Parise, Andrea Milelli, Vincenzo Tumiatti, Anna Minarini, Paolo Neviani, and Guendalina Zuccari (2015). Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent. Journal of Drug Delivery, 22(5): 590-597.

Arias JL (2013). Liposomes in drug delivery: a patent review. Expert Opin Ther Pat, 23: 1399-1414.

Bochot A and Fattal E (2012). Liposomes for intravitreal drug delivery: a state of the art. J Control Release, 161: 628–634.

Bottaro E and Nastruzzi C (2016). “Off-the-shelf" microfluidic devices for the production of liposomes for drug delivery. Mater Sci Eng C Mater Biol Appl, 64: 29–33.

Bulbake U, Doppalapudi S and Kommineni N (2017). Liposomal formulations in clinical use: an updated review. Pharmaceutic, 9(2): 12.

Burns N, Shuken SR, Mercer JAM (2018), Ladderane lipid compounds and liposomes and methods of preparing and using the same. PNAS (Proceedings of the National Academy of sciences of the united states of America), 115, 37.

Cereda CM, Guilherme VA, Alkschbirs MI, de Brito Junior RB, Tofoli GR, Franz-Montan M, et al., (2016), Liposomal butamben gel formulations: toxicity assays and topical anesthesia in an animal model. J Liposome Res. 1-9.

Channarong S, Chaicumpa W, et al., (2011). Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer’s patch targeting using a polyplex- loaded liposome, AAPS PharmSciTech, 12 (1): 192-200.

Daraee H, Etemadi A, Abbasi E, Aval SF, Kouhi M and Akbarzadeh A. (2016a). Application of gold nanoparticles in biomedical and drug delivery, Artif Cells. Nanomed Biotechnol , 44: 410–422.

Daraee H, Etemadi A, Kouhi M, Alimirzalu S and Akbarzadeh A (2016b). Application of liposomes in medicine and drug delivery, Artif Cells. Nanomed Biotechnol, 44: 381–391.

Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati, Koshki K, Nasrabadi HT and Akbarzadeh A (2014). Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide–β-cyclodextrin copolymer nanoparticles containing albumin. Adv Nanoparticles, 3: 14–22.

Devrim B, Kara A, Vural I and Bozkir A (2016). Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation, Drug Dev Ind Phar, 1–12.

Divakar P, Pavan Kumar, Praveen C, Sowmya C and Suryaprakash Reddy C, (2013). Formulation and in vitro evaluation of liposome containing metformin hydrochloride. International Journal of Pharma and Bio Sciences, 4 (2): 479-485.

Figueiredo M and Esenaliev R (2012). PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors. Journal of Drug Delivery, 767839.

Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, et al., (2016). Antibacterial effects of liposomes containing phospholipid cardiolipin and fluoroquinolone levofloxacin on Mycobacterium tuberculosis with extensive drug resistance Bull Exp. Biol Med, 160: 675–678.

Haisheng He, Yi Lu, Jianping Qi, Quangang Zhu, Zhongjian Chen and Wei Wu, (2019), Adapting liposomes for oral drug delivery – Review, Acta Pharmaceutica Sinica B, 9(1): 36-48.

Hui Yao, Hao Lu, Jun Zhang, Xuemei Xue, Chao Yin, Jun Hu, Rong Zou, Lun Wang and Hanlin Xu (2019). Preparation of Prolonged- Circulating Galangin-Loaded Liposomes and Evaluation of Antitumor Efficacy In vitro and Pharmacokinetics In vivo, Journal of Nanomaterials, (4): 1-9.

Jahadi M, Khosravi-Darani K (2017). Liposomal encapsulation enzymes: from medical applications to kinetic characteristics. Mini Rev Med Chem, 17(4): 366-370.

Kilfoyle B.E, Sheihet L, Zhang Z, Laohoo M, Kohn J and Michniak- Kohn B.B (2012). Development of paclitaxel-TyroSpheres for topical skin treatment. Journal of Controlled Release, 163, (1) : 18–24.

Kim JS (2016). Liposomal drug delivery system. J Pharm Invest, 46: 387–392.

Kumar A, Badde S, et al., (2010). Development and characterization of liposomal drug delivery system for nimesulide, Int J Pharm Pharm Sci, 2 (4): 87- 89.

Lee Y and Thompson DH and Wiley (2017). Stimuli-Responsive Liposomes for Drug Delivery, Interdiscip Rev Nanomed Nanobiotechnol. 9(5): 1450.

Lima, Suyanne Kássia S. Pereira, Ronaldo dos Santos S. Junior, Felipe Pereira da S. Santos, Alyandra de Sousa Nascimento, Chistiane Mendes Feitosa, Juliana de Sousa Figuerêdo, Antonio do Nascimento Cavalcante, Edigênia Cavalcante da C. Araújo, and Mahendra Rai (2018). A Brief Review on the Neuroprotective Mechanisms of Vitexin Layana Karine F. Bio Med Research International, 1-8.

Mazen M, El-Hammadi and Jose L. Arias, (2019), An update on liposomes in drug delivery: Expert openion in therapeutic review

- A patent review, 891-907.

Nahire R, Haldar M. K, Paul S, Mergoum A, Ambre A. H, Katti K. S, Gange K. N, Srivastava D. K, Sarkar K and Mallik S (2013). Polymer-coated echogenic lipid nanoparticles with dual release triggers. Biomacromolecules, 143841–143853.

Olga Popovska, Jana Simonovska, Zoran Kavrakovski and Vesna Rafajlovska (2013). An Overview: Methods for Preparation and Characterization of Liposomes as Drug Delivery Systems. International Journal of Pharmaceutical and Phyto pharmacological Research, 3(3): 182-189.

Patel H, Patel H, et al., (2013). Preparation and characterization of calcium phosphate coated vinblastine sulfate liposome, IJPRBS, 2 (2): 263-280.

Prathyush K, Muthukumaran M and Krishnamoorthy B (2013). Liposomes As Targetted Drug Delivery Systems Present And Future Prospectives: A Review, Journal of Drug Delivery & Therapeutics, 3(4), 195-201.

Radhakrishnan K, Haworth K. J, Huang S. L, Klegerman M. E, McPherson D. D and Holland C. K (2012). Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom. Ultrasound Medical Biology, 38111970–81.

Sercombe L, Veerati T and Moheimani F (2015). Advances and challenges of liposome assisted drug delivery. Front Pharmacol, 6: 286.

Soheyla Honary and Foruhe Zahir (2013). Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2, Tropical Journal of Pharmaceutical Research, 12 (2): 265-273 .

Yilin Zhao, Fuli Cai, Xiangyi Shen and Haijia Su (2020). A high stable pH-temperature dual-sensitive liposome for tuning anticancer drug release. Synthetic and Systems Biotechnology, 5(2), 103-110.

Yu Nie, Li Ji, Hong Ding, Li Xie, Li Li, Bin He, Yao Wu and Zhongwei Gu (2012). Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization, Theranostics, 2(11): 1092-103.

Zhang H, Jiang H, Wang H, Zhao J, Chen B and Wang X (2011). Ultrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistance. Journal of Nanoscience and nanotechnology, 1131834–40.

Zylberberg C and Matosevic S (2016). Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv, 23: 3319–3329.